AGE OF NATURAL MENOPAUSE IN BRCA1/2 MUTATION CARRIERS.

被引：1
|
作者：
Lin, W. T.
Beattie, M.
Chen, L. -M.
Cedars, M.
Oktay, K.
Rosen, M.
机构：
[1] Univ Calif San Francisco, Dept Med, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[2] New York Med Coll, Dept Obstet & Gynecol, Westchester Med Ctr, Hawthorne, NY USA
来源：
FERTILITY AND STERILITY | 2010年 / 94卷 / 04期
关键词：
D O I：
10.1016/j.fertnstert.2010.07.168
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [21] Oophorectomy after Menopause and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
    Kotsopoulos, Joanne
    Lubinski, Jan
    Lynch, Henry T.
    Kim-Sing, Charmaine
    Neuhausen, Susan
    Demsky, Rochelle
    Foulkes, William D.
    Ghadirian, Parviz
    Tung, Nadine
    Ainsworth, Peter
    Senter, Leigha
    Karlan, Beth
    Eisen, Andrea
    Eng, Charis
    Weitzel, Jeffrey
    Gilchrist, Dawna M.
    Blum, Joanne L.
    Zakalik, Dana
    Singer, Christian
    Fallen, Taya
    Ginsburg, Ophira
    Huzarski, Tomasz
    Sun, Ping
    Narod, Steven A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (07) : 1089 - 1096
  • [22] Differential ovarian cancer survival in Ashkenazi BRCA1/BRCA1 carriers.
    Levy-Lahad, E
    Kaufman, B
    Eisenberg, S
    Gottfeld, O
    Beller, U
    Renbaum, P
    Lahad, A
    Catane, R
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A135 - A135
  • [23] Predominance of BRCA2 mutation and estrogen receptor-positive breast cancer among BRCA1/2 mutation carriers.
    Pujol, Pascal
    Yauy, Kevin
    Coffy, Amandine
    Duforet-Frebourg, Nicolas
    Gabteni, Sana
    Daures, Jean-Pierre
    Penault-Llorca, Frederique Madeleine
    Collet, Laetitia
    Thomas, Frederic
    Turnbull, Clare
    Galibert, Virginie
    Rideau, Chloe
    You, Benoit
    Genevieve, David
    Hughes, Kevin S.
    Philippe, Nicolas
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] The ATM variant D1853N in BRCA1 mutation carriers.
    Omaruddin, RA
    Nathanson, KL
    Rebbeck, TR
    Weber, BL
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 105 - 105
  • [25] BRCA1 mutation carriers
    Orli Bahcall
    Nature Genetics, 2013, 45 (4) : 352 - 352
  • [26] Mammographic Density and Breast Cancer in BRCA1/BRCA2 Carriers.
    Pollan, M.
    Ramon y Cajal, T.
    Chirivella, I.
    Miranda, J.
    Teule, A.
    Brunet, J.
    Sanchez-Heras, A. B.
    Llort, G.
    Balmana, J.
    Carvajal, V.
    Hernandez-Agudo, E.
    Juan-Fita, M. J.
    Tena-Garcia, I.
    Robles, L.
    Guillen, C.
    Perez-Segura, P.
    Luque-Molina, M. S.
    Hernando, S.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 : 93 - 93
  • [27] DO BRCA1 AND BRCA2 MUTATION CARRIERS HAVE EARLIER NATURAL MENOPAUSE THAN THEIR NON-CARRIER RELATIVES?
    Collins, I.
    Milne, R. L.
    McLachlan, S. A.
    Friedlander, M.
    Hickey, M.
    Weideman, P.
    Birch, K. E.
    Hopper, J. L.
    Phillips, K. -A.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 54 - 54
  • [28] Genomic features of normal tissues from prophylactic surgery in BRCA1/2 mutation carriers.
    Kotoula, Vassiliki
    Demiri, Efterpi
    Fostira, Florentia
    Vrettou, Eleni
    Charalambous, Elpida
    Tikas, Ioannis
    Papazisis, Konstantinos
    Zaramboukas, Thomas
    Asimaki-Vlachopoulou, Anthoula
    Miliaras, Spyros
    Fountzilas, Elena
    Ananiadis, Ananias
    Chrisafi, Sofia
    Poulios, Christos
    Natsiopoulos, Ioannis
    Tsiftsoglou, Aris
    Fountzilas, George
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
    Osorio, A.
    Milne, R. L.
    Alonso, R.
    Pita, G.
    Peterlongo, P.
    Teule, A.
    Nathanson, K. L.
    Domchek, S. M.
    Rebbeck, T.
    Lasa, A.
    Konstantopoulou, I.
    Hogervorst, F. B.
    Verhoef, S.
    van Dooren, M. F.
    Jager, A.
    Ausems, M. G. E. M.
    Aalfs, C. M.
    van Asperen, C. J.
    Vreeswijk, M.
    Waisfisz, Q.
    Van Roozendaal, C. E.
    Ligtenberg, M. J.
    Easton, D. F.
    Peock, S.
    Cook, M.
    Oliver, C. T.
    Frost, D.
    Curzon, B.
    Evans, D. G.
    Lalloo, F.
    Eeles, R.
    Izatt, L.
    Davidson, R.
    Adlard, J.
    Eccles, D.
    Ong, K-R
    Douglas, F.
    Downing, S.
    Brewer, C.
    Walker, L.
    Nevanlinna, H.
    Aittomaki, K.
    Couch, F. J.
    Fredericksen, Z.
    Lindor, N. M.
    Godwin, A.
    Isaacs, C.
    Caligo, M. A.
    Loman, N.
    Jernstrom, H.
    BRITISH JOURNAL OF CANCER, 2011, 104 (08) : 1356 - 1361
  • [30] Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
    A Osorio
    R L Milne
    R Alonso
    G Pita
    P Peterlongo
    A Teulé
    K L Nathanson
    S M Domchek
    T Rebbeck
    A Lasa
    I Konstantopoulou
    F B Hogervorst
    S Verhoef
    M F van Dooren
    A Jager
    M G E M Ausems
    C M Aalfs
    C J van Asperen
    M Vreeswijk
    Q Waisfisz
    C E Van Roozendaal
    M J Ligtenberg
    D F Easton
    S Peock
    M Cook
    C T Oliver
    D Frost
    B Curzon
    D G Evans
    F Lalloo
    R Eeles
    L Izatt
    R Davidson
    J Adlard
    D Eccles
    K-r Ong
    F Douglas
    S Downing
    C Brewer
    L Walker
    H Nevanlinna
    K Aittomäki
    F J Couch
    Z Fredericksen
    N M Lindor
    A Godwin
    C Isaacs
    M A Caligo
    N Loman
    H Jernström
    British Journal of Cancer, 2011, 104 : 1356 - 1361
12345